You Han Bae

Active 1987–2023

Also published as
You-Han Bae
96
Papers
28,479
Citations
85
h-index
96
i10-index

Citations

Citations per year for You Han Bae1980: 1 citations1988: 2 citations1989: 4 citations1990: 15 citations1991: 19 citations1992: 24 citations1993: 40 citations1994: 25 citations1995: 50 citations1996: 24 citations1997: 38 citations1998: 43 citations1999: 61 citations2000: 92 citations2001: 116 citations2002: 168 citations2003: 136 citations2004: 156 citations2005: 139 citations2006: 183 citations2007: 291 citations2008: 317 citations2009: 330 citations2010: 339 citations2011: 353 citations2012: 387 citations2013: 320 citations2014: 339 citations2015: 276 citations2016: 264 citations2017: 252 citations2018: 221 citations2019: 684 citations2020: 736 citations2021: 641 citations2022: 474 citations2023: 370 citations2024: 499 citations2025: 250 citations2026: 8 citations1981–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 1,785 citing papers, 21% of this breakdownUnited States: 1,704 citing papers, 20.1% of this breakdownSouth Korea: 469 citing papers, 5.5% of this breakdownIndia: 454 citing papers, 5.3% of this breakdownJapan: 307 citing papers, 3.6% of this breakdownGermany: 247 citing papers, 2.9% of this breakdownUnited Kingdom: 246 citing papers, 2.9% of this breakdownIran: 210 citing papers, 2.5% of this breakdownCanada: 202 citing papers, 2.4% of this breakdownItaly: 185 citing papers, 2.2% of this breakdownNetherlands: 167 citing papers, 2% of this breakdownSingapore: 166 citing papers, 2% of this breakdown
0%21%Other 27.6%

Fields

  • Biochemistry, Genetics and Molecular Biology31.1%
  • Materials Science30.1%
  • Medicine11.6%
  • Engineering10.4%
  • Pharmacology, Toxicology and Pharmaceutics7.4%
  • Chemistry2.9%
  • Other6.5%

Topics

  • Nanoparticle-Based Drug Delivery11.5%
  • Hydrogels: synthesis, properties, applications8.6%
  • RNA Interference and Gene Delivery6.8%
  • Nanoplatforms for cancer theranostics5.8%
  • Advanced Drug Delivery Systems5.6%
  • Advanced biosensing and bioanalysis techniques3.5%
  • Other58.2%

Coauthors

All papers

Open in search
  1. The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives

    Authors: , , , , , , , , - Advanced Drug Delivery Reviews 2022 cited by 374

  2. Targeted drug delivery to tumors: Myths, reality and possibility

    Authors: , - Journal of Controlled Release 2011 cited by 1,914

  3. EPR: Evidence and fallacy

    Authors: , - Journal of Controlled Release 2014 cited by 810

  4. Highly cited research articles in Journal of Controlled Release: Commentaries and perspectives by authors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gaylen M. Zentner, Hyesung Kim, Hyuk Sang Yoo, Masamichi Nakayama, Teruo Okano, Zi‐Xian Liao, Er‐Yuan Chuang, Chun‐Wen Hsiao, Hsing‐Wen Sung, Horacio Cabral, Kazunori Kataoka, Praful R. Nair, Dennis E. Discher, Samir Mitragotri - Journal of Controlled Release 2014 cited by 787

  5. Bile acid transporter-mediated oral drug delivery

    Authors: , - Journal of Controlled Release 2020 cited by 132

  6. Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery

    Authors: , , , , , , , , , , , , , , - Nature Nanotechnology 2016 cited by 411

  7. Perspectives on the past, present, and future of cancer nanomedicine

    Authors: , - Advanced Drug Delivery Reviews 2018 cited by 286

  8. Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport

    Authors: , , , , - ACS Nano 2018 cited by 187

  9. Thermosensitive sol–gel reversible hydrogels

    Authors: , , - Advanced Drug Delivery Reviews 2002 cited by 1,455

  10. Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins

    Authors: , , , , , , , - Acta Pharmaceutica Sinica B 2019 cited by 167

  11. Hydrogels: Swelling, Drug Loading, and Release

    Authors: , , - Pharmaceutical Research 1992 cited by 646

  12. Nanoparticle oral absorption and its clinical translational potential

    Authors: , , - Journal of Controlled Release 2023 cited by 50

  13. Bile Acid Conjugation on Solid Nanoparticles Enhances ASBT‐Mediated Endocytosis and Chylomicron Pathway but Weakens the Transcytosis by Inducing Transport Flow in a Cellular Negative Feedback Loop

    Authors: , , , - Advanced Science 2022 cited by 47

  14. Biodegradable block copolymers as injectable drug-delivery systems

    Authors: , , , - Nature 1997 cited by 1,993

  15. Advanced drug delivery 2020 and beyond: Perspectives on the future

    Authors: , - Advanced Drug Delivery Reviews 2020 cited by 149

  16. Tumor pH-responsive flower-like micelles of poly(l-lactic acid)-b-poly(ethylene glycol)-b-poly(l-histidine)

    Authors: , , , , - Journal of Controlled Release 2007 cited by 443

  17. Recent progress in tumor pH targeting nanotechnology

    Authors: , , - Journal of Controlled Release 2008 cited by 847

  18. Tumor heterogeneity and its implication for drug delivery

    Authors: , - Journal of Controlled Release 2012 cited by 142

  19. Thermoreversible Gelation of PEG−PLGA−PEG Triblock Copolymer Aqueous Solutions

    Authors: , , - Macromolecules 1999 cited by 611

  20. Immune-triggered cancer treatment by intestinal lymphatic delivery of docetaxel-loaded nanoparticle

    Authors: , , - Journal of Controlled Release 2019 cited by 61

  21. Drug targeting and tumor heterogeneity

    Authors: - Journal of Controlled Release 2008 cited by 233

  22. Ovalbumin and Poly(i:c) Encapsulated Dendritic Cell‐Targeted Nanoparticles for Immune Activation in the Small Intestinal Lymphatic System

    Authors: , , , - Advanced Healthcare Materials 2022 cited by 33

  23. Odyssey of a cancer nanoparticle: From injection site to site of action

    Authors: , - Nano Today 2012 cited by 363

  24. Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice

    Authors: , , , - Journal of Controlled Release 2013 cited by 220